Authors

• Lanyan Fang (ORCID: https://orcid.org/0000-0001-5378-2948)
• Liang Zhao (ORCID: https://orcid.org/0000-0002-0257-9082)
• Eleftheria Tsakalozou (ORCID: https://orcid.org/0000-0003-1993-8528)
• Stella Grosser
• Bhagwant Rege
• Ke Ren (ORCID: https://orcid.org/0000-0003-3272-142X)
• Partha Pratim Roy (ORCID: https://orcid.org/0000-0003-2357-3234)
• Sivacharan Kollipara (ORCID: https://orcid.org/0000-0002-7332-9021)
• Zhigang Zhu (ORCID: https://orcid.org/0000-0002-9990-1137)
• Timothy Nicholas
• Erin Skoda

Institutions

• United States Food and Drug Administration (US)
• Center for Drug Evaluation and Research (US)
• Pfizer (United States) (US)
• Dr. Reddy's Laboratories (India) (IN)

Publication Details

Journal

Pharmaceutical Research

Published

2025-03-07

DOI

https://doi.org/10.1007/s11095-025-03839-x

Primary Topic

Health Systems, Economic Evaluations, Quality of Life

Type

article

Field-Weighted Citation Impact

0.00

Funders

• U.S. Food and Drug Administration